Inflammatory Myofibroblastic Tumor of the Liver After Adrenal Neuroblastoma Surgery: a Case Report

Overview

Journal Discov Oncol

Publisher Springer

Specialty Oncology

Date 2024 May 18

PMID 38761221

Authors

Qiyang Shen

Xingyu Liu

Lijie Zhang

Tao Li

Jianfeng Zhou

Affiliations

Soon will be listed here.

Abstract

A boy aged 55 months was diagnosed with stage IV Neuroblastoma (NB) of the right adrenal gland 2 years ago. Preoperative chemotherapy was given and he was then treated with retroperitoneal tumor resection and lymph node dissection. After surgery, the children were transferred to the Hemato-Oncology Department for chemotherapy according to the high-risk group NB, with outpatient follow-up every 6 months. In the second postoperative year, abdominal computed tomography (CT) scan revealed a rounded hypodense area in the upper part of the right posterior lobe of the liver, with marked inhomogeneous enhancement in the venous phase after enhancement, which was surgically resected, and postoperative pathology confirmed inflammatory myofibroblastic tumor (IMT) of liver. The patient was not given any special treatment after surgery. In this study, whole transcriptome sequencing was performed on the postoperative specimen of adrenal NB and the specimen of IMT of liver. This unusual case emphasizes the need for close monitoring of second tumor development in NB survivors even in the absence of known predisposing factors.

References

Applebaum M, Henderson T, Lee S, Pinto N, Volchenboum S, Cohn S . Second malignancies in patients with neuroblastoma: the effects of risk-based therapy. Pediatr Blood Cancer. 2014; 62(1):128-33. PMC: 4237647. DOI: 10.1002/pbc.25249. View

Park K, Kang S, Lee H, Chung Y . Olfactory neuroblastoma following treatment for pituitary adenoma. J Neurooncol. 2008; 90(2):237-41. DOI: 10.1007/s11060-008-9657-7. View

Hawkins M, Bhatia S, Henderson T, Nathan P, Yan A, Teepen J . Subsequent Primary Neoplasms: Risks, Risk Factors, Surveillance, and Future Research. Pediatr Clin North Am. 2020; 67(6):1135-1154. DOI: 10.1016/j.pcl.2020.07.006. View

Applebaum M, Vaksman Z, Lee S, Hungate E, Henderson T, London W . Neuroblastoma survivors are at increased risk for second malignancies: A report from the International Neuroblastoma Risk Group Project. Eur J Cancer. 2016; 72:177-185. PMC: 5258837. DOI: 10.1016/j.ejca.2016.11.022. View

Baird D, Meyers G, Hu J . Testicular Cancer: Diagnosis and Treatment. Am Fam Physician. 2018; 97(4):261-268. View

Castle J, Levy B, Rodeberg D . Abdominal Tumors: Wilms, Neuroblastoma, Rhabdomyosarcoma, and Hepatoblastoma. Surg Clin North Am. 2022; 102(5):715-737. DOI: 10.1016/j.suc.2022.07.006. View

Fabius A, van Hoefen Wijsard M, van Leeuwen F, Moll A . Subsequent Malignant Neoplasms in Retinoblastoma Survivors. Cancers (Basel). 2021; 13(6). PMC: 8001190. DOI: 10.3390/cancers13061200. View

Breslow N, Lange J, Friedman D, Green D, Hawkins M, Murphy M . Secondary malignant neoplasms after Wilms tumor: an international collaborative study. Int J Cancer. 2009; 127(3):657-66. PMC: 2878923. DOI: 10.1002/ijc.25067. View

Martin A, Schneiderman J, Helenowski I, Morgan E, Dilley K, Danner-Koptik K . Secondary malignant neoplasms after high-dose chemotherapy and autologous stem cell rescue for high-risk neuroblastoma. Pediatr Blood Cancer. 2014; 61(8):1350-6. DOI: 10.1002/pbc.25033. View

10.

Westerveld A, van Dalen E, Asogwa O, Koopman M, Papadakis V, Laureys G . Neuroblastoma survivors at risk for developing subsequent neoplasms: A systematic review. Cancer Treat Rev. 2022; 104:102355. DOI: 10.1016/j.ctrv.2022.102355. View

11.

Attarbaschi A, Carraro E, Ronceray L, Andres M, Barzilai-Birenboim S, Bomken S . Second malignant neoplasms after treatment of non-Hodgkin's lymphoma-a retrospective multinational study of 189 children and adolescents. Leukemia. 2020; 35(2):534-549. DOI: 10.1038/s41375-020-0841-x. View

12.

Filips A, Maurer M, Montani M, Beldi G, Lachenmayer A . Inflammatory myofibroblastic tumor of the liver: A case report and review of literature. World J Hepatol. 2020; 12(4):170-183. PMC: 7336290. DOI: 10.4254/wjh.v12.i4.170. View

13.

Li Y, Han W, He L, Zheng W, Zhang W . Inflammatory Myofibroblastic Tumor After Treatment of Wilms Tumor in a 6-Year-Old Boy: A Case Report and Literature Review. Urology. 2020; 149:e25-e28. DOI: 10.1016/j.urology.2020.11.012. View

14.

Uttinger K, Riedmeier M, Reibetanz J, Meyer T, Germer C, Fassnacht M . Adrenalectomies in children and adolescents in Germany - a diagnose related groups based analysis from 2009-2017. Front Endocrinol (Lausanne). 2022; 13:914449. PMC: 9363694. DOI: 10.3389/fendo.2022.914449. View

15.

Guan X, Wei R, Yang R, Lu Z, Liu E, Zhao Z . Association of Radiotherapy for Rectal Cancer and Second Gynecological Malignant Neoplasms. JAMA Netw Open. 2021; 4(1):e2031661. PMC: 7794669. DOI: 10.1001/jamanetworkopen.2020.31661. View

16.

Zhen H, Guan H, Ma J, Wang W, Jing S, Miao Z . Risk of developing second malignant neoplasms in patients with neuroblastoma: a population study of the US SEER database. Radiat Oncol. 2021; 16(1):228. PMC: 8626885. DOI: 10.1186/s13014-021-01943-x. View

17.

Yalcin B, Kremer L, Caron H, van Dalen E . High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma. Cochrane Database Syst Rev. 2010; (5):CD006301. DOI: 10.1002/14651858.CD006301.pub2. View

18.

Cairo S, Urias A, Murphy J . Pediatric Abdominal Malignancies and Intravascular Extension: Contemporary Single-Center Experience. J Surg Res. 2022; 280:396-403. DOI: 10.1016/j.jss.2022.06.046. View

19.

Keegan T, Bleyer A, Rosenberg A, Li Q, Goldfarb M . Second Primary Malignant Neoplasms and Survival in Adolescent and Young Adult Cancer Survivors. JAMA Oncol. 2017; 3(11):1554-1557. PMC: 5824209. DOI: 10.1001/jamaoncol.2017.0465. View

20.

Webb T, Slavish J, George R, Look A, Xue L, Jiang Q . Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy. Expert Rev Anticancer Ther. 2009; 9(3):331-56. PMC: 2780428. DOI: 10.1586/14737140.9.3.331. View